JB Pharma records revenue growth of 36% to INR 809 crores in Q2 FY23
Operating EBITDA* grew by 44% to INR 202 crores Mumbai (Maharashtra) [India], November 12: JB Pharma, one of the fastest…
JB Pharma
Read More
Operating EBITDA* grew by 44% to INR 202 crores Mumbai (Maharashtra) [India], November 12: JB Pharma, one of the fastest…